KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$332.29
+2.38%Forward multiples
Based on analyst estimates
- P/E forward
- 39.59x
- P/E 2026E
- 44.69x
- P/E 2027E
- 36.96x
- P/E 2028E
- 26.26x
- P/S forward
- 16.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 40.18x
- PEG TTM
- 26.40x
- Price / book
- 7.24x
- Price / sales
- 22.33x
- Price / cash flow
- 36.11x
Enterprise value
- Enterprise value
- $9.0B
- EV / sales
- 20.43x
- EV / EBITDA
- 40.90x
- EV / EBIT
- 45.47x
- Market cap
- $9.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026